Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention 2024-05-11 15:14
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology 2024-05-11 10:16
Zepp Health Corporation Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price 2024-05-11 05:00
Momcozy Celebrates Motherhood with "Momcozy Village" Event at Babylist Beverly Hills 2024-05-10 22:00
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering 2024-05-10 21:20
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) 2024-05-10 20:07
Nuvilab Becomes B Corp Certified 2024-05-10 19:59
Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides 2024-05-10 18:39
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval 2024-05-10 12:16
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer 2024-05-10 12:00
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost 2024-05-10 07:41
Origin Agritech Receives GMO Safety Certificate for its Triple Stack Maize 2024-05-09 20:30
FDA Clears the Individualized Nomogram for Rika Plasma Donation System 2024-05-09 20:00
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines 2024-05-09 15:30
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery 2024-05-09 15:00
Front Street Re Appoints Edison Fong as Chief Executive Officer 2024-05-08 21:22
NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia 2024-05-08 21:00
TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain 2024-05-08 20:00
Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting 2024-05-08 18:18
Andall Biosciences Introduces 23WELL: A Breakthrough New Brand with Ovary Care Capsules (1+1) as its Stellar Debut Product 2024-05-08 18:11
1 33 34 35 36 37 812